Tags

Type your tag names separated by a space and hit enter

Acceptability of human papillomavirus vaccine for males: a review of the literature.
J Adolesc Health. 2010 Feb; 46(2):113-23.JA

Abstract

The quadrivalent human papillomavirus virus vaccine was recently licensed for use in males in the United States. This study reviews available published literature on acceptability among parents, health care providers, and young males. Among 23 published articles, half were conducted in the United States. The majority (87%) used quantitative survey methodology, and 13% used more explorative qualitative techniques. Convenience samples were used in most cases (74%) and 26% relied on nationally representative samples. Acceptability of a human papillomavirus virus (HPV) vaccine that protects against cervical cancer and genital warts was high in studies conducted among male college students (74%-78%) but lower in a community sample of males (33%). Among mothers of sons, support of HPV vaccination varied widely from 12% to 100%, depending on the mother's ethnicity and type of vaccine, but was generally high for a vaccine that would protect against both genital warts and cervical cancer. Health providers' intention to recommend HPV vaccine to male patients varied by patient age but was high (82%-92%) for older adolescent patients. A preference to vaccinate females over males was reported in a majority of studies among parents and health care providers. Messages about cervical cancer prevention for female partners did not resonate among adult males or parents. Future acceptability studies might incorporate more recent data on HPV-related disease, HPV vaccines, and cost-effectiveness data to provide more current information on vaccine acceptability.

Authors+Show Affiliations

Division of STD Prevention, National Centers for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. nliddon@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20113917

Citation

Liddon, Nicole, et al. "Acceptability of Human Papillomavirus Vaccine for Males: a Review of the Literature." The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, vol. 46, no. 2, 2010, pp. 113-23.
Liddon N, Hood J, Wynn BA, et al. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010;46(2):113-23.
Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: a review of the literature. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, 46(2), 113-23. https://doi.org/10.1016/j.jadohealth.2009.11.199
Liddon N, et al. Acceptability of Human Papillomavirus Vaccine for Males: a Review of the Literature. J Adolesc Health. 2010;46(2):113-23. PubMed PMID: 20113917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptability of human papillomavirus vaccine for males: a review of the literature. AU - Liddon,Nicole, AU - Hood,Julia, AU - Wynn,Bridget A, AU - Markowitz,Lauri E, PY - 2009/09/22/received PY - 2009/11/09/revised PY - 2009/11/10/accepted PY - 2010/2/2/entrez PY - 2010/2/2/pubmed PY - 2010/4/20/medline SP - 113 EP - 23 JF - The Journal of adolescent health : official publication of the Society for Adolescent Medicine JO - J Adolesc Health VL - 46 IS - 2 N2 - The quadrivalent human papillomavirus virus vaccine was recently licensed for use in males in the United States. This study reviews available published literature on acceptability among parents, health care providers, and young males. Among 23 published articles, half were conducted in the United States. The majority (87%) used quantitative survey methodology, and 13% used more explorative qualitative techniques. Convenience samples were used in most cases (74%) and 26% relied on nationally representative samples. Acceptability of a human papillomavirus virus (HPV) vaccine that protects against cervical cancer and genital warts was high in studies conducted among male college students (74%-78%) but lower in a community sample of males (33%). Among mothers of sons, support of HPV vaccination varied widely from 12% to 100%, depending on the mother's ethnicity and type of vaccine, but was generally high for a vaccine that would protect against both genital warts and cervical cancer. Health providers' intention to recommend HPV vaccine to male patients varied by patient age but was high (82%-92%) for older adolescent patients. A preference to vaccinate females over males was reported in a majority of studies among parents and health care providers. Messages about cervical cancer prevention for female partners did not resonate among adult males or parents. Future acceptability studies might incorporate more recent data on HPV-related disease, HPV vaccines, and cost-effectiveness data to provide more current information on vaccine acceptability. SN - 1879-1972 UR - https://www.unboundmedicine.com/medline/citation/20113917/Acceptability_of_human_papillomavirus_vaccine_for_males:_a_review_of_the_literature_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1054-139X(09)00608-9 DB - PRIME DP - Unbound Medicine ER -